# The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

> **NCT04554043** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 118 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** SHR7280
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04554043
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-11
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04554043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04554043, "The PK/PD Study of SHR7280 Tablets in Healthy Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04554043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*